Suppr超能文献

巴尔他霉素,一种由拟无枝酸菌属Y-86,21022产生的新型糖肽抗生素。分类学、生产、分离及生物活性

Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.

作者信息

Nadkarni S R, Patel M V, Chatterjee S, Vijayakumar E K, Desikan K R, Blumbach J, Ganguli B N, Limbert M

机构信息

Microbiology Department, Hoechst India Limited, Mulund (W), Bombay.

出版信息

J Antibiot (Tokyo). 1994 Mar;47(3):334-41. doi: 10.7164/antibiotics.47.334.

Abstract

A new glycopeptide antibiotic, balhimycin, has been isolated from the fermentation broth of a Amycolatopsis sp. Y-86,21022. Balhimycin belongs to the vancomycin class of glycopeptides and contains a dehydrovancosamine sugar. The biological activity of balhimycin has been compared extensively with that of vancomycin against methicillin resistant staphylococci and also against anaerobes. Balhimycin is marginally superior to vancomycin in its in vitro activity against anaerobes and in its bactericidal properties.

摘要

一种新的糖肽类抗生素——巴利霉素,已从一株拟无枝酸菌属菌株Y - 86,21022的发酵液中分离出来。巴利霉素属于糖肽类的万古霉素家族,含有去氢万古糖胺糖。巴利霉素与万古霉素针对耐甲氧西林葡萄球菌以及厌氧菌的生物活性已被广泛比较。在体外对厌氧菌的活性及其杀菌特性方面,巴利霉素略优于万古霉素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验